Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the In Vitro Diagnostics Market from 2026 to 2030?
The in vitro diagnostics market size has seen rapid expansion in recent years. It is anticipated to increase from $136.55 billion in 2025 to $152.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. The historical growth of this market can be attributed to factors such as the expansion of diagnostic testing volumes, an increase in infectious disease screening, the growing burden of chronic diseases, enhancements in laboratory infrastructure, and broader healthcare access.
The in vitro diagnostics market is anticipated to undergo significant growth in the upcoming years. It is predicted to expand to $241.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This expansion during the forecast period can be attributed to the increasing adoption of decentralized diagnostics, rising investments in molecular testing technologies, the proliferation of personalized medicine diagnostics, a growing demand for rapid and accurate testing, and the increasing integration of AI-driven diagnostics. Prominent trends for this period include the wider adoption of point-of-care diagnostic devices, an escalating demand for molecular and immunoassay testing, the increasing use of automated laboratory systems, the expansion of multiplex diagnostic platforms, and an intensified focus on rapid testing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp
What Drivers Are Affecting Demand In The In Vitro Diagnostics Market?
The rising incidence of cancer is predicted to drive expansion within the in vitro diagnostics market. Cancer refers to a wide array of more than 100 distinct diseases that can develop in different parts of the body. This increasing prevalence stems from lifestyle modifications such as elevated tobacco consumption, inadequate nutrition, lack of physical activity, and environmental contaminants, all of which jointly elevate the risk of cancer among populations. In vitro diagnostics (IVDs) are a type of test or medical apparatus used to examine human body samples, providing vital data for the screening, diagnosis, and management of cancer. For example, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported that the United States was projected to experience 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Consequently, the growing occurrence of cancer is projected to further stimulate the in vitro diagnostics market’s growth.
Which Segment Groups Are Influencing The In Vitro Diagnostics Market?
The in vitro diagnostics market covered in this report is segmented –
1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
2) By Type of Expenditure: Public, Private
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing
2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)
3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing
4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices
5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems
6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers
7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters
8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers
What Upcoming Trends Are Likely To Define The Future Path Of The In Vitro Diagnostics Market?
Major companies within the in vitro diagnostics market are integrating advanced technologies such as UIMG image technology and a 2D decoder chip. This adoption aims to enhance the precision and efficiency of diagnostic tests, improve data analysis capabilities, streamline workflow processes, and ultimately deliver superior patient outcomes. UIMG image technology itself is an advanced imaging method utilized in diagnostics to capture and analyze high-resolution images, thereby improving the visualization and interpretation of biological samples. For instance, in November 2023, Newland, an EMEA, Netherlands-based technology company, launched its IVD (in vitro diagnostics) product line. This new line comprises five compact, rugged barcode scanners optimized for automated diagnostic processes. These scanners are designed to improve the speed and accuracy of diagnostics, which is critically important given the increasing demand for efficient healthcare solutions.
Who Are The Top-Performing Companies In The In Vitro Diagnostics Market In Recent Years?
Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The In Vitro Diagnostics Market?
North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized In Vitro Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company
In Vitro Diagnostics Ivd Quality Control Global Market Report 2026
In Vitro Toxicology Testing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
In Vitro Diagnostics Enzymes Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company